Minoryx Therapeutics

Barcelona, Spain

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

Jul 2025

Grant

Biotechnology Genetics Health Care Medical Pharmaceutical

Top Investors

European Investment BankColumbus Venture PartnersYsios CapitalInvereadyKurma Partners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Minoryx Therapeutics

Who are Minoryx Therapeutics's investors?

Minoryx Therapeutics's investors include European Investment Bank, Columbus Venture Partners, Ysios Capital, Inveready, Kurma Partners.

Where is Minoryx Therapeutics headquartered?

Minoryx Therapeutics is headquartered in Barcelona, Spain.

What does Minoryx Therapeutics do?

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

What stage is Minoryx Therapeutics at?

Minoryx Therapeutics is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 10, 2025.

MLA

"Minoryx Therapeutics — Funding & Investors." VCBacked, July 10, 2025, https://www.vcbacked.co/company/minoryx-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2025). Minoryx Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/minoryx-therapeutics

Wikipedia (cite web)

{{cite web |title=Minoryx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/minoryx-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 10, 2025.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver

Rapport Therapeutics

Boston

Neuroglee Therapeutics

Singapore

Living In Silico Inc.